ImmunityBio
IBRX
$7.65
Share price
-1.29%
Change (1 day)
136.84%
Change (1 year)
Categories
Market capitalization of ImmunityBio (IBRX)
Market cap: $5.29 Billion
As of May 2024 ImmunityBio has a market cap of $5.29 Billion. This makes ImmunityBio the world's 2597th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of ImmunityBio from 2021 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $5.29 B | 57.84% |
| 2023 | $3.35 B | 65.15% |
| 2022 | $2.02 B | -16.09% |
| 2021 | $2.41 B |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of ImmunityBio was reported to be:
$5.29 Billion
$5.29 Billion
$5.29 Billion
$5.27 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.61 B | -88.33% | 🇺🇸 USA |